An exciting line up of well respected speakers will be presenting at the IMSANZ-RACPQ 2010 Combined Scientific Meeting.
John Atherton is Director of Cardiology at the Royal Brisbane and Women’s Hospital and Associate Professor, Department of Medicine, University of Queensland. His clinical and research interests include heart failure pathophysiology, quality of care in patients with acute coronary syndromes and heart failure, cardiac genetics and cardiac rehabilitation. He chairs the Asia Pacific Acute Decompensated Heart Failure Registry Scientific Advisory Committee and is the Queensland Board Member for the Cardiac Society of Australia and New Zealand. He sits on the Commonwealth Medical Services Advisory Committee, the National Heart Foundation Chronic Heart Failure Clinical Practice Guidelines Executive Group and the National Heart Foundation Queensland Division’s Health Reference Group.
Con Aroney graduated from the University of Queensland in 1979, and did his cardiology training at Royal Hobart, Royal Brisbane and Prince Charles Hospitals. He gained a Heart Foundation scholarship which allowed him to work as a clinical and research fellow at Harvard Medical School and the Massachusetts General Hospital, Boston, USA, before returning to Brisbane in 1989. In 1991, he was awarded a Doctor-ate in Medicine, from UQ in 1991 for research in heart failure. He served as Director of the Coronary Care Unit at PCH from 1990 till 2005, where he founded the first comprehensive Chest Pain Assessment Unit in Queensland. He is also an interventional cardiologist with a particular interest in the percutaneous treatment of structural heart disease, and has been a Queensland and Australian pioneer, of angioplasty using the radial artery, mitral and aortic balloon valvuloplasty, ASD and PFO closure, alcohol septal ablation, and most recently percutaneous aortic valve implantation. He has served on many national and local Heart Foundation and Cardiac Society committees (Chairman of the national Clinical Issues Committee and Scientific Commit-tee of the CSANZ). Since 2000, he has been the principal author of Heart Founda-tion/CSANZ national guidelines for the management of heart attack and unstable angina. He has authored more than 170 research papers, abstracts and book chapters and has a continuing interest in clinical research and quality assessment programs in cardiology. In 2005, he was named as Queensland Whistleblower of the Year for revelations regarding cardiac cutbacks and deaths due to access block and hidden cardiac waiting lists. He gave evidence on three occasions to the Public Hospitals Royal Commission. These disclosures led to the recommendation that cardiac and other surgical waiting lists, in Queensland be made transparent and available to the public. He is currently Director of Cardiac Services at Holy Spirit Northside Hospital, and a senior visiting cardiologist at The Prince Charles Hospital.
Dr Wayne Stafford is a Cardiologist in private practice with the Queensland Cardiovascular Group and practices full-time at St Andrew's Hospital where he is the Director of Cardiology. He is also co-ordinator of medical student training at St Andrew's Hospital, and Adjunct Professor at the School of Physical and Chemical Sciences, Faculty of Science, Queensland University of Technology. His major interests include cardiac arrhythmia therapies including catheter ablation and implantable cardiac devices. He is Chairman of the Research Committee of the St Andrew's Medical Institute.
Andrew McCann (MBBS (Hons) FRACP) is Director of Vascular Medicine at Princess Alexandra Hospital where he practices as an interventional cardiologist and vascular physician.
A graduate of University of Queensland, Andrew undertook Cardiology training at the Royal Brisbane and Women’s Hospital and The Prince Charles Hospital. Andrew then completed dual fellowships in Interventional Cardiology at The Prince Charles Hospital (2006), and St Vincent’s Hospital, Melbourne (2007-2008). In 2008 Andrew undertook a Clinical and Research Fellowship in Vascular Medicine and Peripheral Endovascular Intervention at Harvard Medical School and the Massachusetts General Hospital, Boston, USA. His clinical and research interests include interventional cardiology/endovascular intervention, vascular diagnostic testing and venous thromboembolic disease.
Beverley Rowbotham trained in clinical and laboratory haematology in Queensland and the Mayo Clinic, Rochester Minnesota. She has maintained an active interest in thrombosis research and anticoagulation throughout her career. The Sullivan Nicolaides Warfarin Care program manages 14000 patients, the vast majority of whom have atrial fibrillation.
Dr Claire Heney qualified and worked in South Africa as a microbiologist before moving to Brisbane 3 years ago. While in South Africa, she held the positions of head of microbiology laboratory at Baragwanath Hospital and consultant microbiologist for a large private laboratory. Since her move to Brisbane, she has spent time at various laboratories in Queensland including Townsville, the Princess Alexandra and Gold Coast Hospitals in addition to attaining the FRCPA and a Masters in International Public Health.
John O’Sullivan is a senior visiting neurologist at the Royal Brisbane & Women’s Hospital, where he conducts Movement Disorders, Botulinum Toxin and Huntington’s Disease Clinics. He is also Associate Professor of Medicine at the University of Queensland and in private neurology practice in Brisbane.
After completing neurology training in Brisbane, John undertook Clinical Movement Disorder Fellowships in Melbourne and in London before returning to Brisbane in 2001. He was awarded a Doctorate in Medicine from Melbourne University in 2000 for studies into surgery for Parkinson’s disease. He maintains a strong clinical and research interest in movement disorders including Parkinson’s disease, Huntington’s disease and dystonia.
Charles Denaro is a general physician and clinical pharmacologist. Trained at Princess Alexandra Hospital in Brisbane and University of California, San Francisco. Currently is the Director of Internal Medicine & Aged Care, Royal Brisbane & Women’s Hospital and Associate Professor of Medicine with the University of Queensland. He has a Doctorate in Medicine in Clinical Pharmacology. Dr. Denaro’s research interests include health systems research, quality use of medicines and cardiovascular therapeutics.
Andrew in a Physician in Dunedin Hospital, affiliated with the University of Otago, practicing in acute Internal Medicine. He is the chair of the SAC for Internal Medicine in New Zealand. He has been a co-writer for the IM curriculum and the basic training curriculum. He is a councillor on the IMSANZ council. He has represented IM on many RACP and IMSANZ committees within Australia and NZ. Andrew is currently working on Electronic Prescribing nationally and electronic medicine management in Otago. He holds the position of Clinical Director in Information Technology.
A graduate of Sydney University who became the first neurology registrar at Royal Prince Alfred Hospital Sydney.
Undertook advance neurology training alongside Dr Walter Bradley at the Muscular Dystrophy Group Research Laboratories at Newcastle upon Tyne under the guidance of Lord Walton of Detchant.
More recently has been the founder and director of the stroke unit at the Gold Coast Hospital and lecturer at the Griffith University Medical School.
The study of headache has always been a passion with membership of the International Headache Society for nearly 30 years attending many of its meetings in order to keep at the fore front of this specialty.
Has had several papers published on rare headaches.
Academic Appointments: Professor of Medicine (Academic Title holder), Central Clinical Division, The School of Medicine, The University of Queensland and Professor, The School of Human Movement Studies (Academic Title holder), The University of Queensland. I was appointed as Director of Renal Research and Pre-eminent Staff Specialist in the Renal Medicine Department at the Royal Brisbane and Women’s’ Hospital Brisbane in September 2008. Research: My research commenced during advanced training in Nephrology in 1980. Subsequently I chose a clinical, teaching and Medical Leadership pathway until 1997. After a seven month sabbatical as visiting Professor with Dr Robert Schrier at the University of Colorado Health Sciences Centre I returned to my role as Director of Medicine and Associate Professor of Medicine determined to advance the research activities at the Launceston General Hospital in Northern Tasmania and in particular in Renal Research in 1998. In 2005 I founded Renal Research Tasmania. While Director of Renal Research Tasmania we conducted over 30 research projects half or which are investigator-initiated studies. Many of these studies are still in progress. I am building collaborations with the Centre for Chronic Kidney Disease and the School of Human Movement Studies at The University of Queensland. In particular in collaboration with Professor Wendy Hoy we have established CKD.QLD a multidisciplinary kidney research group investigating kidney disease in Queensland. This includes a database and population of CKD patients for biomarker studies and clinical trials. I have ongoing research in Tasmania with Associate Professor Ros Bull in Palliative care in kidney disease.
Graham Hall (MBBS 1970, FRACP 1975) is a Senior Visiting Medical Officer in the Department of Internal Medicine at Princess Alexandra Hospital, and his duties include acting as the Director of the Acute Stroke Unit and running a General Medical Unit. He was also in private practice as a Consultant Physician in Internal Medicine from 1979 to 2003. He was Chairman of the Division of Medicine at Princess Alexandra Hospital in 2004. He is a member of the Internal Medicine Society of Australia and New Zealand, and a member of the Stroke Society of Australasia.
Professor Darrell Crawford graduated from The University of Queensland in 1981. He trained in liver disease with Professor Lawrie Powell and was awarded his MD in 1994. He has spent study periods in Southampton (1995) and Birmingham (2001), United Kingdom. Professor Crawford has a special interest in liver diseases, particularly disorders of iron overload, viral hepatitis and hepatic fibrosis. Professor Crawford is a prominent member of the Australian Gastroenterology community and is the immediate past-president of the Gastroenterological Society of Australia and is a past chairman of the Australian Liver Association. He is the Head of the Discipline of Medicine, University of Queensland as well as the Head of the Clinical School at Greenslopes Private Hospital.

Call for Abstracts Open
June 2010
Online Registration Opens
July 2010
Abstract Submission Deadline
2 August 2010
Authors abstract Notification
16 August 2010
Early Bird/Author Registration Deadline
30 August 2010
For further information on accommodation, social events, sponsorship opportunities, please contact the Meeting Managers imsanz-racpq@arinex.com.au
arinex pty limited
ABN 28 000 386 676
arinex pty limited has been appointed as the official PCO (Professional Conference Organiser). arinex is the largest total service provider for conferences, events, business travel and exhibitions in Australia. They are the only Australian partner of INCON, an exclusive international network of the world’s top conference organisers and event managers. They are ideally placed to combine international know how and local expertise to this Meeting and look forward to working with the Organising Committee to produce a memorable Meeting.
Meeting Managers
IMSANZ-RACPQ 2010 Combined Scientific Meeting
Address:
Level 10, 51 Druitt St
Sydney, NSW, 2000, Australia
Ph: + 61 2 9265 0700
Fax: + 61 2 9267 5443
Email: imsanz-racpq@arinex.com.au